EW
CMD

Evoke Wealth’s Cantel Medical Corporation CMD Stock Holding History

Evoke Wealth’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-131
Closed -$9.29K – 1415
2019
Q4 		$9.29K Hold
131
– – ﹤0.01% 769
2019
Q3 		$9.8K Buy
+131
New +$11.1K ﹤0.01% 826

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Evoke Wealth's CMD Position: Q1 2020 in Review

Evoke Wealth sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 131 shares — an estimated $9.29K sold.

Evoke Wealth first reported a position in CMD in Q3 2019 and held it in 2 quarters. The position peaked at $9.8K in Q3 2019. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • Evoke Wealth reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • Evoke Wealth sold 131 Cantel Medical Corporation shares in Q1 2020, an estimated $9.29K.
  • Evoke Wealth first reported a position in Cantel Medical Corporation in Q3 2019 and held it in 2 quarters.
  • Evoke Wealth's Cantel Medical Corporation position peaked at $9.8K in Q3 2019.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Evoke Wealth's 13F filing for Q1 2020, filed 7 May 2020.